全球優碘市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計優碘市場將從 2025 年的 2.0979 億美元成長到 2034 年的 3.2322 億美元，2026 年至 2034 年的複合年成長率為 4.92%。

由於優碘在醫療保健領域被廣泛用作消毒劑和防腐劑，其全球市場正穩步成長。該產品常用於創傷護理、外科手術和感染預防，已成為醫療保健領域不可或缺的成分。感染疾病的上升以及人們衛生和公共衛生意識的增強正在推動市場成長。此外，醫療機構的擴建和外科手術的增加也促進了對優碘產品需求的成長。

推動市場成長要素包括人們對感染控制和醫院衛生標準的日益重視。優碘對多種微生物具有高效的殺滅作用，因此在臨床和居家照護領域的需求不斷成長。製藥和醫療產業的蓬勃發展也進一步促進了市場擴張。此外，公共衛生緊急事件和疫情期間需求的激增凸顯了消毒產品的重要性，並推動了其在全球範圍內的普及應用。

由於配方和產品研發的不斷進步，優碘市場預計將持續成長。旨在提高療效和減少皮膚刺激的創新將增強消費者對產品的接受度。在獸醫和個人衛生用品領域的應用拓展可能會創造新的機會。新興市場預計將因醫療保健意識的提高和醫療用品獲取管道的改善而做出顯著貢獻。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球優碘市場：以劑型分類

• 市場分析、洞察與預測
• 擦洗
• 外部液體
• 軟膏
• 其他

第5章：全球優碘市場：依濃度分類

• 市場分析、洞察與預測
• 10%溶液
• 7.5%溶液
• 其他

第6章 全球優碘市場：依應用分類

• 市場分析、洞察與預測
• 皮膚消毒
• 醫療器械的消毒
• 消毒劑
• 其他

第7章 全球優碘市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Avrio Health LP
  • BASF
  • 3M
  • Boai NKY Pharmaceuticals Ltd
  • Glide Chem Private Limited
  • RN Laboratories Pvt. Ltd
  • Lasa Supergenerics Limited
  • Tosoh
  • Clariant

The Povidone Iodine Market size is expected to reach USD 323.22 Million in 2034 from USD 209.79 Million (2025) growing at a CAGR of 4.92% during 2026-2034.

The global povidone iodine market is growing steadily due to its widespread use as an antiseptic and disinfectant in healthcare settings. It is commonly used for wound care, surgical procedures, and infection prevention, making it an essential component in medical practice. The increasing incidence of infections and the rising awareness about hygiene and sanitation are driving market growth. Additionally, the expansion of healthcare facilities and surgical procedures is contributing to the increasing demand for povidone iodine products.

Key growth drivers include the rising focus on infection control and hospital hygiene standards. Povidone iodine is highly effective against a broad spectrum of microorganisms, which enhances its demand in both clinical and homecare applications. The growing pharmaceutical and healthcare industries are further supporting market expansion. Moreover, increased demand during public health emergencies and pandemics has highlighted the importance of antiseptic products, boosting their adoption worldwide.

Looking ahead, the povidone iodine market is expected to witness sustained growth due to ongoing advancements in formulation and product development. Innovations aimed at improving efficacy and reducing skin irritation will enhance product acceptance. Expanding applications in veterinary care and personal hygiene products are likely to create new opportunities. Emerging markets are expected to contribute significantly due to rising healthcare awareness and improving access to medical supplies.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Formulation Type

• Scrub
• Topical Solution
• Ointments
• Others

By Concentration

• 10% Solution
• 7.5% Solution
• Others

By Application

• Skin Sterilization
• Instrument Sterilization
• Disinfectant
• Others

COMPANIES PROFILED

• Avrio Health LP, BASF, 3M, Boai NKY Pharmaceuticals Ltd, Glide Chem Private Limited, RN Laboratories Pvt Ltd, Lasa Supergenerics Limited, Tosoh, Clariant
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL POVIDONE IODINE MARKET: BY FORMULATION TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Formulation Type
• 4.2. Scrub Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Topical Solution Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Ointments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL POVIDONE IODINE MARKET: BY CONCENTRATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Concentration
• 5.2. 10% Solution Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. 7.5% Solution Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL POVIDONE IODINE MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Skin Sterilization Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Instrument Sterilization Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Disinfectant Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL POVIDONE IODINE MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Formulation Type
  • 7.2.2 By Concentration
  • 7.2.3 By Application
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Formulation Type
  • 7.3.2 By Concentration
  • 7.3.3 By Application
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Formulation Type
  • 7.4.2 By Concentration
  • 7.4.3 By Application
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Formulation Type
  • 7.5.2 By Concentration
  • 7.5.3 By Application
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Formulation Type
  • 7.6.2 By Concentration
  • 7.6.3 By Application
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL POVIDONE IODINE INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Avrio Health L.P
  • 9.2.2 BASF
  • 9.2.3 3M
  • 9.2.4 Boai NKY Pharmaceuticals Ltd
  • 9.2.5 Glide Chem Private Limited
  • 9.2.6 R.N Laboratories Pvt. Ltd
  • 9.2.7 Lasa Supergenerics Limited
  • 9.2.8 Tosoh
  • 9.2.9 Clariant